// App-Quantinova.ai

2557 : A phase 1 study of phospholipid ether [131I]-CLR1404 in patients with advanced solid tumors.

Researchers

Presenter

  • Sam Joseph Lubner

Principal Investigators

  • Jacqueline Ann Mullvain

  • Katherine Oliver

  • Jennifer Heideman

  • Jamey Weichert

  • Glenn Liu

  • Lance T. Hall

  • Michael Pishavian

  • Joanne E. Mortimer

Medical Centers

  • Univeristy of Wisconsin, Madison, WI

  • City of Hope, Duarte, CAUniversity Wisconsin Carbone Cancer Center, Madison, WINovelos Therapeutics, Madison, WI

  • Georgetown University, Washington, DC

  • University of Wisconsin Comprehensive Cancer Center, Madison, WI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT01495663

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved